Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118 Article

Corn, Benjamin W, Moughan, Jennifer, Knisely, Jonathan PS et al. (2008). Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118 . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 71(1), 71-78. 10.1016/j.ijrobp.2007.09.015

Open Access International Collaboration

cited authors

  • Corn, Benjamin W; Moughan, Jennifer; Knisely, Jonathan PS; Fox, Sherry W; Chakravarti, Arnab; Yung, WK Alfred; Curran, Walter J; Robins, H Ian; Brachman, David G; Henderson, Randal H; Mehta, Minesh P; Movsas, Benjamin

sustainable development goals

authors

publication date

  • May 1, 2008

webpage

published in

keywords

  • CELL LUNG-CANCER
  • CHEMOTHERAPY
  • COGNITIVE FUNCTION
  • HIGH-GRADE GLIOMA
  • Life Sciences & Biomedicine
  • MENTAL-STATE-EXAMINATION
  • MOTEXAFIN GADOLINIUM
  • OUTCOME RESEARCH
  • Oncology
  • PHASE-II
  • Radiology, Nuclear Medicine & Medical Imaging
  • SURVIVAL
  • Science & Technology
  • TUMORS
  • brain metastases
  • neurocognition
  • quality of life
  • thalidomide
  • whole-brain radiotherapy

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

start page

  • 71

end page

  • 78

volume

  • 71

issue

  • 1